Comparing cost/utility of giving an aromatase inhibitor as monotherapy for 5 years versus sequential administration following 2-3 or 5 years of tamoxifen as adjuvant treatment for postmenopausal breast cancer (Q46788567)
Jump to navigation
Jump to search
scientific article published on 2 November 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Comparing cost/utility of giving an aromatase inhibitor as monotherapy for 5 years versus sequential administration following 2-3 or 5 years of tamoxifen as adjuvant treatment for postmenopausal breast cancer |
scientific article published on 2 November 2005 |
Statements
1 reference
Comparing cost/utility of giving an aromatase inhibitor as monotherapy for 5 years versus sequential administration following 2-3 or 5 years of tamoxifen as adjuvant treatment for postmenopausal breast cancer (English)
1 reference
P E Lønning
1 reference
2 November 2005
1 reference
1 reference
17
1 reference
2
1 reference
217-225
1 reference
Identifiers
1 reference
1 reference